Current Insight Into Retinal Disease Management: Focus on DME and Intravitreal Corticosteroids
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Overview
This continuing medical education (CME) activity captures content from a CME roundtable discussion held in October 2014 in Chicago, IL. This certified CME activity is designed for retina specialists and general ophthalmologists involved in the management of patients with retinal disease Learning Objectives
Upon completion of this activity participants should be able to: - Understand the present an anticipated public health burden attributed to diabetic eye disease and DME
- Differentiate existing DME therapy options from recent primary and secondary treatment
- Interpret clinical research data comparing laser therapy to new DME treatment protocols
- Review the use of intravitreal steroids as single and combined approaches to DME
- Define complications and strategies to minimize vision loss with intravitreal steroids
- Educate patients about treatment regimens and risks associated with DME
- Improve practice management issues encountered with retinal therapies
Faculty and Disclosures
DISCLOSURE POLICY
Allen C. Ho, MD Director of Retina Research at Wills Eye Hospital Professor of Ophthalmology Thomas Jefferson University Philadelphia, PA Chief Medical Editor, Retina Today Michael D. Ober, MD Retina Consultants of Michigan Member, Adjunct Teaching Faculty Department of Ophthalmology Henry Ford Health Systems Detroit, MI SriniVas R. Sadda, MD Professor of Ophthalmology Doheny Eye Institute University of Southern California Los Angeles, CA Rishi P. Singh, MD Staff Physician Cole Eye Institute, Cleveland Clinic Medical Director of the Clinical Systems Office Cleveland Clinic Assistant Professor of Ophthalmology Case Western University Cleveland, OH
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The Dulaney Foundation and Retina Today. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Yewlin E. Chee, MD
Camila Ventura MD, PhD
Edward Wood, MD
Tony Capone Jr, MD
Katherine E. Talcott, MD
Nassim Abreu, MD
- CME/CE In-Person & Virtual Event
Treating Outside the Box: New Pathways to Retinal Vascular Stability
July 17, 2026
Montreal Katherine E. Talcott, MD
Roger A. Goldberg, MD, MBA
